Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Pre-treatment with Flupirtine exerts a protective effect on hippocampal and striatal neuronal damage and on deficits in spatial learning in rats with cerebral ischemia
over a period of 21 days) exhibits robust in vivo efficacy in two Pim kinases driven tumor models
Cisplatin forms highly reactive
CPI-169 potently inhibits wild-type EZH2
3-benzoxadiazol-4-yl)-2
BS-181 14361 Pre-treatment with Flupirtine exerts aNormal progression through the cell cycle requires the sequential action of cyclin dependent kinases (CDK1, CDK2, CDK4 and CDK6). Deregulation of CDK activity is a feature of almost all cancers and has led to the development of CDK inhibitors as anticancer agents. As such, CDK7 is an target for the anticancer drug development. Computer modeling of CDK7 was used to design potential potent CDK7 inhibitor, which is BS 181. Product information CAS Number: